// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

A retrospective study of the use of ROX index to predict failure in patients receiving CPAP for COVID-19

Asfandyar Yousuf - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The impact of the COVID-19 pandemic on a domiciliary non-invasive ventilation (D-NIV) service referral

Stephanie K. Mansell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

The effect of the COVID-19 pandemic on response times for acute non-invasive ventilation (NIV) set-ups

David Inglis - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial

Rebecca D'Cruz - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The impact of an admission avoidance rapid response respiratory car in collaboration with the Northwest Ambulance Service

Emma Rickards - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Patient perspective of participation in COVID-19 clinical trials

Karolina Krassowska - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Budesonide

Rethinking COPD Exacerbations: a global patient perspective

Chris Mwasuku - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Use of Clinical Nurse Specialists in the Management of Incidental Pulmonary Nodules

Marcus Anthony Pittman - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A training needs analysis of UK respiratory nurses’ research capability and capacity

Emma Ray - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The SWISS Nurse; respiratory nursing care without any borders. An admission avoidance winter pressure initiative

Emma Rickards - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A negotiation of respiratory risk in the first phase of the Covid-19 pandemic

Lindsay Welch - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Was our step-down virtual covid ward safe and effective?

David Jennings - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Anxiety

N/A

Impacts on length of stay and costs associated with treating severe COVID-19 stratified by age

J. Morel Symons - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Impact of particle exposure systems on acute effects in an in vitro alveolar model

Joshua Bateman - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Differential toxicities of particulate matter components linked to air pollution and adverse health effects

Sofie Orell - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Staff mask contamination on a respiratory admissions unit with COVID-19 patients

Ahmed Fouda - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

A qualitative study of the barriers facing primary healthcare professionals in identifying occupational asthma

Gareth Walters - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Occupational asthma in school teachers

Sherwood Burge - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Occupational Asthma in Office Workers: A Cross-Sectional Study

Christopher C. Huntley - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Stay home; save lives; aid the diagnosis of occupational asthma

Vicky Moore - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Copyright © 2026. QuantiNova All rights reserved